IMS 2023 | Clonal hematopoiesis in multiple myeloma and implications for therapy
Enrique Ocio
• 29 Sep 2023
Enrique Ocio, MD, PhD, Marquis of Valdecilla University Hospital, Santander, Spain, shares some insights into a session that took place at this year’s meeting which focused on clonal hematopoiesis (CH) in multiple myeloma, and further highlights how this may impact therapy and clinical practice in the future. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
